Global Health Limited · NSE:MEDANTA
Global Health — Q3 FY2026 Earnings Presentation
37 slides from Global Health's earnings presentation, Feb 4, 2026
Slide 1: Exchange filing cover letter for investor presentation
February 04, 2026 Ref:- GHL/2025-26/EXCH/100 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 05
Slide 2: Investor Presentation Q3 and 9M FY2026
GLOBAL HEALTH LIMITED Dedicated to Life Investor Presentation Q3 and 9M FY2026 5 4th February, 2026 1
Slide 3: Disclaimer
Disclaimer This presentation, apart from historical information, contains some "forward-looking statements" including those describing the Company’s strategies, strategic direction, objectives, future prospects, estimates etc. These forward-looking statements involve a number of risks, uncertainties
Slide 4: Contents
Contents 01 Q3 and 9M FY2026 Performance Update 02 Project Update and Capex Plan 03 Medanta’s Journey, Purpose and Model of Healthcare 04 Annexures 3
Slide 5: Q3 and 9M FY2026 Performance Update
01 Q3 and 9M FY2026 Performance Update 4
Slide 6: Q3 FY2026 performance summary
Q3 FY2026 performance summary Strong quarter with Revenue Growth of 19% y-o-y and EBITDA ex Noida growth of 11% y-o-y Total Income1 EBITDA3 and Margins Profit after Tax and Margins EBITDA2 ex Noida Reported EBITDA Adjusted PAT4 Reported PAT INR 11,428 million INR 2,814 million INR 2,494 million INR
Slide 7: Q3 FY2026 performance summary
Q3 FY2026 performance summary Revenue growth of 19% y-o-y, primarily led by increase in patient volumes and realization • Total Income was INR 11,428 million, up by 19.1 % y-o-y • EBITDA (ex-Noida) was INR 2,814 million, up by 10.9 % y-o-y, with margins of 25.4% • EBITDA Including Noida, was INR 2,4
Slide 8: Q3 FY2026 business update
Q3 FY2026 business update 144 beds added in Q3 FY26 and deploying latest medical technologies to deliver clinical excellence Capacity Expansion New Medical Equipment Deployed in Q3 FY26 Group: Total of 144 beds added in Q3 FY26. Total 537 beds addition in 9M FY26 Patna: Total of 42 beds added in
Slide 9: Medanta Noida fully operational with 300+ beds
Medanta Noida fully operational with 300+beds Formally inaugurated on 27th November, 2025. 328 beds and 14 OTs were operational at the end of Q3 FY26 Medanta Noida Overview 550+ 328 Planned beds capacity Operational beds 200+ 36 Experienced Doctors Directors 60+ 25+ Senior clinicians Super Specialit
Slide 10: Latest advanced technology deployed at Noida
Latest advanced technology deployed at Noida Providing the latest tools to enable our doctors to deliver the greatest care SOMATOM Pro. O-arm O2 Surgical ARTIS icono BiPlane Pulse Imaging System CATH Lab Dual Source CT Lumenis Pulse 100H Holmium ARTIS icono Ceiling MAGNETOM Lumina Laser with Abbott
Slide 11: Key operating metrics: Revenue and profitability
Key operating metrics: Revenue and profitability In 9M FY26 Total Income and EBITDA, excluding Noida, grew by 16% y-o-y Total Income (INR million) +16.2% +17.6% 32,749 33,131 28,172 +15.5% +19.1% 9,595 11,189 11,085 11,428 9M FY25 9M FY26 ex Noida 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 ex Noida Q3 FY26 EBI
Slide 12: Key operating metrics: Revenue and profitability
Key operating metrics: Revenue and profitability PBT growth on a y-o-y basis for both the nine months and the quarter was impacted by higher depreciation arising from the Noida hospital, along with increased non-cash expenses related to ESOPs. Profit before tax (INR million and margin %) +2.7% 5,138
Slide 13: Key operating metrics: Volumes, occupancies, ALOS
Key operating metrics: Volumes, occupancies, ALOS Occupied bed days grew by 7%, driven by in-patient volume growth of 14% y-o-y; ALOS improvement of 6%, occupancy of 59% on increased bed capacity Average census and occupied beds per day ALOS (days) +6.8% -4.1% -6.5% +9.1% +15.0% 3.17 3.04 3.23 3.06
Slide 14: Key operating metrics: ARPOB and revenue mix
Key operating metrics: ARPOB and revenue mix ARPOB growth driven by improvement in ALOS and change in specialty mix ARPOB* (INR) IPD Revenue mix by payor category** +6.5% +9.9% 62,424 66,501 65,570 67,361 57% 56% 55% 56% 56% 61,307 25% 10% 26% 27% 10% 25% 12% 25% 12% 4% 4% 5% 4% 5% 4% 11% 3% 3% 3% 3
Slide 15: Diverse revenue mix
Diverse revenue1 mix Significant contribution from complex specialties Heart 21.5% 20.7% 20.4% 20.7% 20.3% Cancer 13.5% 14.4% 13.4% 14.5% 14.6% Digestive 11.4% 11.6% 11.3% 12.1% 11.4% Neuro 11.3% 11.3% 11.5% 11.0% 11.5% Kidney & Urology 7.6% 7.7% 7.4% 7.4% 8.0% Internal Medicine 6.8% 5.8% 7.4% 5.8%
Slide 16: 9M FY2026: Matured portfolio registered steady growth
9M FY2026: Matured portfolio registered steady growth Growth in matured hospitals led by volume and case mix change Matured hospitals - Over 6 years Total Income (INR million) EBITDA (INR million and margin %) +8.4% +4.5% 19,579 21,226 4,796 5,011 +9.4% +6.7% 6,418 7,020 1,569 1,675 9M FY25 9M FY26
Slide 17: 9M FY2026: Developing portfolio continues to register strong growth
9M FY2026: Developing portfolio continues to register strong growth Developing hospitals, ex Noida, registered robust Revenue and EBITDA growth in 9M FY2026 Developing hospitals – Less than 6 years Total Income (INR million) EBITDA (INR million and margin %) +28.0% +32.7% +32.8% +10.4% 10,401 10,783
Slide 18: Project Update and Capex Plan
02 Project Update and Capex Plan 17
Slide 19: Delhi: Strengthening our presence with ~1,000 beds planned
Delhi: Strengthening our presence in the region with a planned capacity of ~1,000 beds Expanding into the high-growth, densely populated micro markets of Northwest and South Delhi Super specialty hospital in North West Delhi Super specialty hospital in South Delhi *The artistic image for illustratio
Slide 20: Medanta to enter Mumbai market with 750+ bed hospital
Medanta to enter Mumbai market with a state-of-the-art, 750+ bedded super-specialty hospital at Oshiwara, Mumbai Super specialty hospital in Oshiwara, Mumbai Approval for additional 4 FSI has been received and the requisite payment has been made in January 26. Total FSI available for the project i
Slide 21: Medanta to set up 400+ bedded hospital in Guwahati
Medanta to set up 400+ bedded super-specialty hospital in Guwahati 400+ Bedded Super specialty hospital in Guwahati *The artistic image for illustration purpose only Barricading Completed, soil testing complete. Consultant on-boarding in progress Temporary electricity connection approval receive
Slide 22: Completing the campus
Completing the campus Establishing world class medical college and guest house for out of city patients Medanta Guest House Medanta Medical College *The artistic image for illustration purposes only *The artistic image for illustration purposes only • Medanta to construct a service apartments / gues
Slide 23: On-going expansion projects
On-going expansion projects Planned bed capacity addition; well positioned to drive near term growth Number of installed beds ~ 2,300 bed addition +56.4% 537 bed addition +17.7% 496 bed addition 400 ~219 bed addition +13.9% 750 +7.8% 750 81 400 193 222 2,823 110 328 6,375 219 99 3,042 3,579 4,075 31
Slide 24: Capex plan next 5 years
Capex plan next 5 years Total capex of over ~INR 39,013 million planned for next 5 years 2,387 3,000 4,515 5,835 39,013 13,808 33,626 3,430 4,500 832 706 Maintenance Lucknow, Noida South Mumbai Pitampura, Guwahati Medical Guest Total Capex Capex for 3 Patna and Delhi- DLF Delhi School House Years Ra
Slide 25: Medanta's Journey, Purpose and Model of Healthcare
Medanta’s Journey, Purpose and 03 Model of Healthcare 24
Slide 26: Medanta was founded to bring a new type of healthcare to India
Medanta was founded to bring a new type of healthcare to India… … the human side of healthcare Healthcare is never only about science. It is also about the art of medicine – the human connection, putting the patient first, collaboration, the personal acts of empathy and the values that guide our dec
Slide 27: Growth from a single flagship hospital in Gurgaon
Growth from a single flagship hospital in Gurgaon… …to a network of 6 high quality hospitals across north India FY2026 MEDANTA 2025 HOSPITAL MEDANTA 2021 HOSPITAL NOIDA JAI PRABHA 550 Beds Ranchi 2 2019 MEDANTA SPECIALTY 328 currently 110 Beds operational MEDANTA HOSPITAL Commenced including 81 ICU
Slide 28: From our flagship Medicity campus we have grown to ~3,550+ beds
From our flagship Medicity campus in Gurgaon, we have grown to ~3,550+ beds across 6 cities Largest private hospital beds in operation under one roof in Delhi (NCR), Uttar Pradesh and Bihar Gurgaon LUCKNOW PATNA 1,440 beds; 316 ICU beds 757 beds; 202 ICU beds (950 planned) 569 beds; 147 ICU beds (65
Slide 29: One of the largest private hospital chains in North and East India
One of the largest private hospital chains in North and East India Serving over 400 million people in the States with Medanta facilities Gurugram; Largest single location private hospital in with operational Delhi; ~1,150 bed addition bed capacity of 1,440 Our Network planned with 750 beds in Pitamp
Slide 30: Our Mission and Values
Our Mission and Values Embracing a new era and redefining our purpose Core Values Patient centric care: Foster a culture where every one of us is MISSION committed to care for patients and their caregivers Our mission is to deliver Leadership and quality: Commit to delivering excellence in world cla
Slide 31: The Medanta Model of Healthcare
The Medanta Model of Healthcare Delivering the highest quality of medicine with care and compassion Exceptional clinical talent What it means for patients and caregivers? • Super specialized doctors provide the highest quality of care through a team based integrated approach Trust based compassionat
Slide 32: Medanta is well placed to deliver sustainable growth
Medanta is well placed to deliver sustainable growth… …while maintaining its core values of patient centric care and clinical leadership and quality CONTINUITY OF CARE TECHNOLOGY Extend clinical THOUGHT ADVANCEMENT services outside LEADERSHIP Use technology to hospital and ENHANCE Build on our impro
Slide 33: Annexures
04 Annexures 32
Slide 34: Annexure: Profit and Loss Statement
Annexure: Profit and Loss Statement Nine Months Quarter Y-o-Y Y-o-Y INR million 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 Growth % Growth % Revenue from operations 27,611 32,511 17.7% 9,434 10,992 11,210 18.8% Other income 562 620 10.3% 160 197 218 35.9% Total income 28,172 33,131 17.6% 9,595 11,189 1
Slide 35: Annexure: Operational Parameters
Annexure: Operational Parameters Year End Quarter Y-o-Y Growth Y-o-Y Growth Q-o-Q Growth Key metrics 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 % % % Total Beds 3,042 3,579 17.7% 3,042 3,435 3,579 17.7% 4.2% Census Beds 2,427 2,665 9.8% 2,480 2,658 2,851 15.0% 7.3% Occupied Bed Days 415,731 453,544 9.1
Slide 36: Annexure: Abbreviations and Definitions
Annexure: Abbreviations and Definitions Abbreviations INR : Indian Rupee NABH : National Accreditation Board for Hospitals & Healthcare Providers NABL : National Accreditation Board for Testing and Calibration Laboratories JCI : Joint Commission International OPD : Out-Patient Department
Slide 37: Contact us
Contact us About Medanta Contact Details Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and Ravi Gothwal – cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest Head of Investor Relations civilian awards in India, a